Tuesday’s Active Stock included Pharmacyclics Inc. (NASDAQ:PCYC), Coca-Cola Company (NYSE:KO), Salesforce.com, Inc (NYSE:CRM) and WESCO International Inc. (NYSE:WCC) Viasystems Group (NASDAQ:VIAS)

617

By Chris Hillman on August 28, 2014 Technology & Software

Salesforce.com (NYSE:CRM), the world’s paramount CRM platform, says that its new workers were given equity according to the company’s 2014 Inducement Equity Incentive Plan; these workers had joined Salesforce.com (NYSE:CRM) from RelateIQ Inc. after the company was acquired by Salesforce.com (NYSE:CRM). The Plan was accepted and taken up by the Board of Directors in July 2014, in agreement with New York Stock Exchange Rule 303A.08. 5.74 million shares of Salesforce.com, Inc (NYSE:CRM) were traded on Tuesday and the stock jumped up during the trading session by 0.69%; the share value closed at a figure of $59.64. Company’s insider ownership is 0.30%.

On Thursday Coca-Cola Co (NYSE:KO) said that cash worth $2.15 billion will be paid to Monster Beverage Corp (NASDAQ:MNST) in exchange for a 16.7 percent share in the company. Coca-Cola Co (NYSE:KO) is taking this step with the hope to expand and tap the lucrative market for energy drinks. On Tuesday, the Coca-Cola Company (NYSE:KO) shares closed at a value of $41.60. The net profit margin of the company is at 18.10% whereas its equity return is 25.40%. Coca-Cola Company (NYSE:KO)’s stock range over 52 weeks has been between $36.83 and 42.57.

WESCO International (NYSE:WCC)’s earnings for the second quarter failed to meet Zacks estimates by a figure of 4%; the earnings were recorded at $1.29/share. The good news was that a sequential increase by 32.5% was seen in earnings with a 3.0% increase on a YoY basis. The bottom line performance for the company increased because of better Canadian and organic sales and pipeline acquisition. The company’s stock closed Tuesday’s session at a value of $83.34 with a stagnant profit margin of 3.30%. WESCO International Inc. (NYSE:WCC) equity return is recorded at 13.80%.

On 18 Aug 2014 Pharmacyclics, Inc. (NASDAQ:PCYC) revealed that Shawn Cline Tomasello as the company’s new Chief Commercial Officer (CCO). Ms. Cline Tomasello is a thirty year industry veteran and Celgene Corporation’s former President of the Americas, Hematology and Oncology; during her reign she helped the corporation earn revenue of $4 billion. Before joining Celgene, Ms. Cline Tomasello was the National Director of Hematology for Rituxan®at Genentech and was responsible for over $1.7 billion in earnings and profit. This Tuesday the shares of Pharmacyclics Inc. (NASDAQ:PCYC) closed at $120.24. In 2014, Company’s Company’s growth in Earnings per Share for the year 2014 has been -45.30%, which is expected to reach over 42.90% next year. Pharmacyclics Inc. (NASDAQ:PCYC)’s Beta is 0.75.

Viasystems Group, Inc. (NASDAQ:VIAS) provides circuit boards that are printed with complex multi layers; the company revealed its second quarter results on the 5^th of August; the quarter ended on the 30^th of June. During Tuesday’s session, shares of Viasystems Group, Inc. (NASDAQ:VIAS) went up by 4.76% and ended the session at a value of $11.22. The stock’s asset return is -1.60% whereas its investment return stands at 1.80%. Viasystems Group, Inc. (NASDAQ:VIAS) has a 0.19 ratio for price to sales.